Balloon angioplasty without stent
Delay elective noncardiac surgery for at least 14 days
2026 AHA/ACC guideline: COR I, LOE C-LD
Use the site-wide Search control for: PCI, balloon, BMS, DES, ACS, DAPT, CABG, 100 days, myocardial infarction, NSTEMI, STEMI, stroke, and TIA.
Showing 11 / 11 records
Delay elective noncardiac surgery for at least 14 days
2026 AHA/ACC guideline: COR I, LOE C-LD
Elective surgery requiring antiplatelet interruption within 30 days may be harmful
2026 AHA/ACC guideline: COR III (Harm), LOE B-NR
Ideally delay elective surgery ≥12 months; time-sensitive surgery may be considered ≥3 months after PCI in selected cases
2026 AHA/ACC guideline: elective COR I / LOE B-NR; time-sensitive COR IIb / LOE B-NR
If antiplatelet interruption is required, delay elective surgery ≥6 months; selected time-sensitive surgery may be considered ≥3 months after PCI
2026 AHA/ACC guideline: elective COR IIa / LOE B-NR; time-sensitive COR IIb / LOE B-NR
An observational study found a risk-curve inflection around 100 days; this is not a guideline-defined minimum interval
2025 JACC: Advances retrospective national database study; not a COR/LOE guideline recommendation
In older revascularized patients, 90–180 days may be a reasonable elective-surgery optimization window; do not generalize to all MI
2025 JAMA Surgery Medicare observational study; not a universal guideline interval
Elective noncardiac surgery: delay at least 3 months after the most recent event
2026 AHA/ACC guideline: COR IIa, LOE B-NR
Symptomatic carotid stenosis: perform revascularization as soon as appropriate, preferably within 14 days; after CEA, no universally validated fixed delay exists for unrelated elective surgery
ESVS 2023: revascularization within 14 days, Class I / Level A; interval to unrelated NCS after CEA: insufficient evidence
For symptomatic stenosis requiring revascularization within 14 days, CEA is preferred over CAS; after CAS, no universal fixed interval for unrelated NCS is established, and premature DAPT interruption should be avoided
ESVS 2023: CEA preferred when revascularization is required in first 14 days, Class I / Level A; direct evidence for NCS timing after CAS is lacking
No universally applicable fixed waiting interval is established by high-quality guidelines; assess elective surgery individually after hematoma stability, cause/BP control, correction of coagulopathy, and neurologic stabilization
2022 AHA/ASA spontaneous ICH guideline: no universal interval for elective non-neurosurgical procedures; this remains an evidence gap
After successful TAVI, NCS may be performed early when clinically indicated; evidence supports surgery within 30 days (no routine mandatory 30-day delay)
2026 AHA/ACC perioperative guideline (reaffirming 2024): COR IIa, LOE B-NR
For professional education and decision support. Verify each case against the current full guideline and multidisciplinary assessment.
| Scenario | Key timing | Evidence type |
|---|---|---|
| PCI: balloon / BMS / DES | 14 days / 30 days / 3, 6, 12 months | AHA/ACC guideline |
| After CABG | Approx. 100-day risk inflection | 2025 observational study; not a guideline minimum |
| After NSTEMI | 30 days, 90 days, 90–180-day research signal | 2025 JAMA Surgery observational study |
| After ischemic stroke / TIA | ≥3 months | AHA/ACC guideline COR 2a / LOE B-NR |
| PCI type / indication | Elective surgery delay | Time-sensitive surgery | COR / LOE |
|---|---|---|---|
| Balloon angioplasty without stent | At least 14 days | No generally applicable shorter safe interval; individualize | I / C-LD |
| Bare-metal stent (BMS) | At least 30 days | Elective surgery requiring antiplatelet interruption within 30 days may be harmful | III (Harm) / B-NR |
| Drug-eluting stent (DES) for ACS | Ideally at least 12 months | May be considered ≥3 months after PCI if delay risk outweighs cardiac risk | Elective I / B-NR; time-sensitive IIb / B-NR |
| DES for chronic coronary disease (CCD) | At least 6 months | May be considered ≥3 months if delay risk outweighs cardiac risk | Elective IIa / B-NR; time-sensitive IIb / B-NR |
| BMS or DES implanted ≤30 days | Do not perform elective NCS requiring interruption of ≥1 antiplatelet agent | If surgery cannot be deferred, multidisciplinary decision-making is required | III (Harm) / B-NR |
Clinical notes:
A 2025 national database study, Evaluation of the Timing to Noncardiac Surgery following Cardiac Operations: A National Analysis (JACC: Advances, 2025), included US adults undergoing CABG, valve, or combined cardiac surgery followed by NCS during 2016–2020.
Record CABG date and concomitant valve surgery; wound/sternal healing; residual ischemia, heart failure, arrhythmia, anemia, renal dysfunction or infection; LV function and functional capacity; NCS urgency and bleeding risk; and ongoing DAPT. If feasible, approximately 100 days may be discussed as an observational risk-optimization signal. Urgent surgery should not be automatically cancelled solely because 100 days have not elapsed.
Guideline status: the reaffirmed 2026 AHA/ACC perioperative guideline emphasizes appropriate evaluation/treatment of ACS and deferral of elective surgery when ACS is present. It does not provide one universal waiting interval after any MI independent of PCI status, LV function, and clinical stability.
Key study: Glance et al. Time Since Prior NSTEMI and Major Adverse Cardiovascular and Cerebrovascular Events After Noncardiac Surgery. JAMA Surgery. 2025;160(1):45–54. DOI: 10.1001/jamasurg.2024.4683.
Interpretation:
In patients with prior stroke or transient ischemic attack (TIA), it is reasonable to delay elective NCS for ≥3 months after the most recent cerebrovascular event to reduce recurrent stroke, MACE, or both. COR 2a; LOE B-NR.
Guideline recommendations and observational evidence are distinguished. COR/LOE are shown only when specified in the source; grades are not invented for observational studies.
For professional education and decision support. This database does not replace full guidelines, specialty consultation, institutional policy, or individualized clinical judgment. Emergency surgery should not be delayed solely because of one time threshold.
Version record: Checked 2026-11-19. The 2026 AHA/ACC guideline has been reaffirmed. CABG and NSTEMI timing signals are observational evidence and require ongoing review and local clinical validation.